Clinical Trials Supply Chain Congress 2016 Europe


The clinical trial supplies market is expected to reach USD 1,274.3 million by 2020 from USD 904.3 million in 2015, at a CAGR of 7.1%. (Reportlinker’s Clinical Trial Supplies Market by Products & Services, Phases & Therapeutic Areas – Global Forecast to 2020 2015).

The driving forces behind this phenomenon is the globalization of clinical trial activities, upwards in R&D investments and government support, rising incidences of various diseases and growing expansion activities by CROs.

With these in mind, Clinical Trials Supply Chain Global Congress 2016 Europe is being organised to provide a unique platform for business knowledge sharing and convergence of top tier government, pharmaceuticals, biopharmaceuticals, as well as regional and local manufacturers to discuss the driving macroeconomic factors, policies and issues that will steer the clinical trials supply chain industry.

Who Will You Meet

Presidents, Heads/Chiefs, Directors, VPs and Managers of:

• Clinical Supply Chain
• Clinical Supply Specialist
• Clinical Operations
• Clinical Coordination
• Clinical Supply Planning
• Clinical Materials
• Clinical Logistics / Distribution
• Clinical Purchasing
• Clinical Packaging / Labelling
• Clinical Manufacturing
• Clinical Technical Specialist
• Comparator Specialist/ Sourcer
• Vendor Management/ Contracting
• Lean Processes
• Sourcing

Gain Latest Insights On

• PROCESS EXCELLENCE: How Much Influence Does Clinical Trial Supply Has On the Entire Planning Process?
• FLEXIBLE SCHEDULING: Coordinating a Project Efficiently
• STORAGE AND DISTRIBUTION: Maintaining Quality and Product Integrity
• PATIENT-CENTRIC APPROACH: Improving Clinical Trial Supply Chain

david-jefferys Dr David Jefferys, Senior Vice President – Global Regulatory, Public Affairs, EISAI, UK
David is currently Senior Vice president in Eisai, responsible for Global Regulatory, Government Relations, Public Affairs and Product Safety. After qualifying in medicine, he practised as a physician and cardiologist, with additional interests in metabolic medicine and
clinical toxicology. He spent 21 years as a senior regulatory in the UK and Europe. He was executive director of licensing in MCA, CPMP member, chairman of the MRFG and PER committees. He was CEO and Director of the UK Medical Devices Agency and on the creation
of the MHRA acting joint chief executive. He worked on secondment at the EMEA /EMA on benefi t risk methodologies.

Since 2005 he has worked for Eisai, currently he is also chairman of the ABPI regulatory committee and a member of the Innovation Board. Within Efpia he chairs the Regulatory Committee and sits on the International Regulatory Board.

He also co -chairs the IFPMA regulatory policy, standards and technical committee (RPTS). He is a past chairman of both RAPS and TOPRA and currently serves as the external relations adviser to the TOPRA Board.

He is a past chairman of the CMR Advisory Board and currently sits as a member of the CIRS Scientifi c advisory Council.

virginie-roux Virginie Roux, TSOM Leader, Clinical Supplies SCP – Studies & Distribution, SANOFI, FRANCE
2001: Human Resource Trainer – French Chamber of Commerce and Industry in Morocco
2004-2007: IMP Logistic Manager at Clinical Supply Chain – Sanofi R&D Montpellier
2007-2010: Supply Chain Trial Manager, Leader in the Internal Medicine Projects at Clinical Supply Chain – Sanofi R&D Montpellier
2010-2013: Distribution Project Manager at Clinical Supplies Scientifi c Core Platform – Sanofi R&D Montpellier
2013-today: TSOM Leader: manager of a projects managers’ team in charge of the packaging and the distribution of supplies (IMP)
for R&D and GMA studies at Clinical Supplies Scientifi c Core Platform – Sanofi R&D Montpellier

leyla Leyla Hannbeck, Chief Pharmacist, National Pharmacy Association
Leyla is a pharmacist by profession and an expert in UK and EU medicines and pharmacy policy and practice, patient safety and medicines adherence, medicines management and commissioning and NHS policies. She currently holds the role of Chief Pharmacists
at the National Pharmacy Association (NPA) leading a team of healthcare professionals and has the overall accountability for the NPA policy and practice support functions, learning and development for healthcare professionals and business development functions.
Leyla represents the organisation and its members to stakeholders and the media and regularly works with commissioners and decision-makers in infl uencing policies related to medicines and healthcare. Leyla is also Medicines Safety Offi cer on behalf of all
pharmacy organisations with less than 50 branches working very closely with NHS England and Medicines Health regulatory Agency

carlos-r-cammozzi Dr. Carlos R. Camozzi, Chief Medical Offi cer, ORPHAZYME, DENMARK
Dr. Carlos Camozzi is the Chief Medical Offi cer of Orphazyme (Denmark). He has more than 25 years’ experience in the biopharmaceutical industry, most recently (10 years) within the orphan drugs development and paediatric therapeutic options, and successful achievements
of products approvals by both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Prior to Orphazyme, Dr. Camozzi held roles of increasing responsibility at American Cyanamid (Lederle), Roche and Mepha Ltd. He was the Medical Director of Orphan Europe-Recordati and VP-Chief Medical Offi cer of uniQure BV (ex-AMT) for the development of genetherapy (GT) for rare diseases, getting the fi rst ever GT approval (Glybera) in western world.

Since 2009, Alexander Natz is Secretary General of the European Confederation of Pharmaceutical Entrepreneurs ( in
Brussels and works as lawyer in his own law fi rm in Düsseldorf ( From 2008 to 2013, he was Head of the Brussels
Offi ce of Bundesverband der Pharmazeutischen Industrie e.V. (BPI). Before, he has been a lawyer with Sträter Law Firm in Germany
with a special focus on discount agreements and licensing of pharmaceuticals. Dr. Natz also was working in the fi eld of competition
law with the European Commission and the pharmaceutical industry. As research assistant at Duke University (USA) he has dealt with
international pharmaceutical law. His doctorate was supervised by former judge at the European Court of Justice, Prof. Dr. Dr. Ulrich

michel-mikhail Dr. Michel Mikhail, Pharmaceutical industry Expert, Germany
Dr. Dr. Michel Mikhail has more than 25 years Pharmaceutical Industry experience and track record of achievement in R & D and International Regulatory Affairs in large multinational Research-based pharmaceutical companies as well as in the Generic industry.
Dr Mikhail is a Chartered Expert in Pharmacology -Toxicology, he is a chartered Clinical Expert as well as a chartered Analytical Expert. Dr Mikhail is an Expert in Biosimilars. He served on the Safety working group and Effi cacy working Group of the European Federation
of pharmaceutical Industry associations (EFPIA) also as a Topic leader. He served on the Regulatory Group of the European branch of the Pharmaceutical Research and Manufacturers of America (PhRMA Europe), on the Board, Executive Committee and the Biosimilars & Regulatory and Scientifi c Affairs Group of the European Generic medicines Association (EGA), as well as on different associations and organisations. He is member of The Organisation for Professionals in Regulatory Affairs (TOPRA). Dr Mikhail is and member of the Expert Committee of the Federal Institute for Risk Assessment, Berlin, and member of the Expert Committee for Toxicology of the United States Pharmacopea (USP), Washington DC.

michael-richter Dr. Michael Richter,
Education: Biochemist (University Halle and University Ulm, Germany)
Job Experiences
Science, Marketing, Microbiology
Since 1999 in Investigational Medical Product department F. Hoffmann La- Roche Basel
Clinical Demand and Supply Leader 2005 – 2015
Head Simulation Clinical Supply Chain 2009-2015
Since May 2015: Quality Manager for IMP Europe, deputy Responsible Person IMP

Piete-Kassen Pieter Kassen

laween-alatroshie Laween Al-Atroshi, Chief Research Officer, Mid-Essex Hospital NHS Trust.
Laween Al-Atroshi, was seconded to Central Government (UK Department of Health) for a year to the Clinical Governance Team. He is currently the Chief Research Offi cer for Mid-Essex NHS Trust. The Trust provides a county-wide plastics, head and neck and upper
gastrointestinal (GI) surgical centre to a population of 3.4 million and a world renowned supra regional burns service at the St Andrew’s Centre, that serves a population of 9.8 million. He is the Good Clinical Practice program lead for North Thames network and also was Labour Party’s Parliamentary candidate for Surrey Heath. In his spare time, he is involved in philanthropic activities where he guests on programmes across the media. Recently, he was a
speaker at the Exclusive Digital Marketing Innovation Summit in London on ‘Marketing Hurdles Digital Media Must Overcome’.

samanthat-carnicj Dr Samantha Carmichael, Lead Pharmacist Clinical Trials / R&D, Clinical R & D, NHS GREATER GLASGOW AND CLYDE
Samantha Carmichael has over 20 years experience as a pharmacist, having spent time in many different areas of pharmacy, including hospital pharmacy and within the private sector working for a large international pharmaceutical company. She is currently the Lead
Pharmacist for Clinical Trials and Research & Development within NHS Greater Glasgow & Clyde where she is also one of the Lead Sponsor Representatives when they act as a non-commercial sponsor of studies . NHS Greater Glasgow & Clyde is the largest
healthboard in the UK, providing healthcare services to a population of 1.2 million in the West of Scotland. She manages a team of pharmacists and pharmacy technicians who deliver on studies sponsored by NHS GGC or co-sponsored with the University of Glasgow,
as well as hosting around 400 CTIMPs across all phases and therapeutic areas. She has practised as a clinical pharmacist in the areas of oncology, critical care and anaesthetics. As well as her Pharmacy degree from the University of Strathclyde, she received an MSc
in Clinical Pharmacology from the University of Glasgow and a PhD in Population Pharmacokinetics, from the University of Edinburgh.

Senior Representative from Sanofi , India – Awaiting Photo and Bio

Senior Representative from Takeda UK – Awaiting Photo and Bio

08:00 Registration

09:00 Chairperson’s Opening Remarks


09:10 Achieving Process Excellence in the End-to-End Clinical Trial Supply Chain

• Recognising clinical trial supply chain as a key component to the planning process
• What fundamental improvements should be incorporated in the clinical trial supply chain in progressing the growth of pharmaceutical and
biotechnology companies?

09:50 What Are Some of the Strategies and Approaches in Optimising the Clinical Trials Supply Chain?

• Review regulatory considerations pertaining to patient safety and aligning your organisation’s clinical strategies effectively
• What are some of the ways organisations can stay compliant and up to speed with global and regional regulations?
• Identify issues which are delaying your supply chain
• How can you build best practice risk management approach into your clinical trial supply chain?
Dr. Laween Al-Atroshi, Chief Research Offi cer, MID-ESSEX HOSPITAL NHS TRUST
Samantha Carmichael, Lead Pharmacist Clinical Trials, NHS Greater Glasgow & Clyde

10:30 Morning Break & Networking

11:10 Costs Explained: How Can Companies Cut Costs in Clinical Trials Supply Chain Whilst Maintaining Safety and Effi cacy of Their Products?

• What are some of the ways at which companies can reduce costs whilst mitigate risks?
• What are some of the solutions available and how effective are these solutions?
• How can outsourcing of clinical trials supply and logistics services reduce costs ensure that materials reach trial sites in a timely,
effi cient manner?
Dr. Bernd Steffens, Director and Global Head Clinical Trial Supplies Unit, BOEHRINGER INGELHEIM*

11:50 End-to-End Approach in Clinical Supply Chain – The Challenge of Blinding

• Kit separation as reason for unblinding accidents in clinical trials and how to avoid it
• packaging strategies to avoid unblinding accidents
• I(x)R support to avoid unblinding accidents
• challenges for blinding at bulk level
• quality by design instead of quality by control in release process
Dr. Michael Richter, Quality Manager – Global Clinical Supply, ROCHE, SWITZERLAND

12:30 Networking Lunch

13:30 Clinical trial Regultion and update on its delayed implementation till 2018 instead of 2016.
• EU Clinical Trial Regulation Update
• Background/Effective date/ transition period
• Key provisions/Benefits
• Single Authorisation
• EU Clinical Trial Portal and Database – Critical Path
Dr. Michel Mikhail, Phamaceutical Industry Expert, Germany

14:10 The EU Clinical Trial Regulation: What You Need to Know

• What are the advantages for pharma companies with the new regulation?
• What do companies have to do to prepare for the new regulation?
Dr. David Jefferys, Senior Vice President – Global Regulatory, Public Affairs, EISAI, UK

14:50 Tea Break & Networking

15:30 How Has the New European Good Distribution Practice (GDP) Increased the Demand for Clinical Trials Supply Chain Industry?
• What roles do pharmaceutical companies play in preparing for inspections concerning the new GDP guidelines and what must be done
to collaborate with their supply chain providers?
• How has the requirement of temperature controlled handling and storage for pharmaceuticals change the industry and what must the industry
do to remain competitive?
• How can companies strategise a good risk-based approach for organising modes of transport and transport processes whilst working with third
party logistics provider?

16.10 Medicines storage, record-keeping, pharmacovigilance, professional indemnity etc?

Leyla Hannbeck, Chief Pharmacist, NATIONAL PHARMACY ASSOCIATION

16:50 Industry forecast and expectations do not match NHS reality
Pieter J. Klaassen, Director, Previously Operations Manager in the NHS

17:30 Chairperson’s Closing Remark & End of Day 1

17:30 – 18:30 Networking Drinks

08:00 Registration

08:45 Chairperson’s Opening Remarks


09:10 Lean and Mean: Lean Management as a Tool to Improve the Clinical Trial Supply Clinical Supply Logistics for Investigator-Initiated Studies (giving perspective of an academic sponsor – I would included some aspects of patient considerations that we give as we have insight to sponsor & site needs/challenges.)
• Understanding the system impact of the lean management implementation clinical supply chain
• How will lean operation affect cost whilst ensuring treatment and supply continuity?
Samantha Carmichael, Lead Pharmacist Clinical Trials, NHS Greater Glasgow & Clyde

09:50 Direct To Patient: Delivery of clinical trial materials from an investigator site, pharmacy, or depot directly to a patient’s home

• Context & Objectives/Advantages
• Process Overview & Regulatory Considerations
• Detailed Procedure
Virginie Roux, TSOM Leader, Clinical Supplies SCP – Studies & Distribution, SANOFI, FRANCE

10:30 Morning Break & Networking

11:10 What Effi cient Methods Are Available When Labelling and Packaging Products?

• How to label time and temperature sensitive products?
• What technologies are available and how will these technologies continue to drive the clinical trials logistics industry?

11:50 Case Study: Ensuring The Safety and Effi cacy of Vaccine Supply for Use in Clinical Trials

• What must sponsors and supply chain managers do to ensure the safe passage of vaccines?
Dr. Amgad Gamil, Senior Director, Vaccines Global Medical Development and Scientifi c/Clinical Affairs, PFIZER*

12:30 Networking Lunch


13:30 The Patient-Centric Approach: Improving the Clinical Trial Supply Chain

• What does it truly mean to be patient-centric?
• How can supplies infl uence the patient experience?
• What approaches can stakeholders take to ensure patients’ needs are met?
Dr. Carlos Camozzi, Chief Medical Offi cer, ORPHAZYME, DENMARK
Dr. Laween Al-Atroshi, Chief Research Offi cer, MID-ESSEX HOSPITAL NHS TRUST
Samantha Carmichael, Lead Pharmacist Clinical Trials, NHS Greater Glasgow & Clyde

14:10 Direct-to-Patient Distribution Model: Driving Effi ciencies and Improving the Patients’ Experience

• How can sponsors ensure that clinical trial materials are delivered to patients’ home on time and within product specifi cations?
• How to determine that trial materials and specimens are packaged and classifi ed properly according to the country’s regulatory requirements?
Dr. Carlos Camozzi, Chief Medical Offi cer, ORPHAZYME, DENMARK

14:50 Tea Break & Networking

15:30 Opportunities and Challenges for Clinical Research in Emerging Markets

• The challenges in keeping up-to-date on the latest clinical trial regulations and what are the strategies to overcome these challenges?
• How can companies cope with the rapid patient enrollment such as China and India?
• How can companies ensure that healthcare professionals are trained to conduct trials in emerging markets?
Senior Representative from SANOFI, India

16:10 What Technologies Are Available Today to Ensure the Safety and Data Accuracy of Clinical Trials?

• How will technology for clinical trials logistics evolve to cater to multi-location trials?
• How can new technology contribute to the safety and data accuracy of clinical trials?
• How will this change affect emerging markets?
Senior Representative from TAKEDA, UK

16:50 Chairperson’s Closing Remark & End of Conference

spon-multifarma Multipharma

As a partner for your individually-tailored comparator sourcing solutions, our multinational team offers
you all-round service from the planning stage through to material reconciliation. This service includes
market research, procurement, storage, logistics / distribution as well as project management support
for your trials. Our worldwide presence and network enables us to fulfill these services throughout the
duration of your trial. Additional areas of focus of Multipharma include pre-marketing and the sale of
non-licensed pharmaceuticals, including controlled substances, on an individual import basis.

spon-prysm PRISYM ID
World Class Label Management Software
PRISYM ID designs and delivers label management software for organizations that need complete
product auto-identification and lifecycle traceability. With the continual tightening of labeling
regulations and audits, PRISYM ID empowers its clients to safeguard their reputation by ensuring
compliance, removing risk and significantly reduce costs by eliminating recalls through labeling
errors. PRISYM ID is the market leader in providing validatable world-class label lifecycle
management, and is trusted for delivering personalized service excellence to clients.

Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. For further information please visit:



PharmaVOICE magazine provides commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE’s more than 25,000 BPA-qualified subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers. For further information please visit:



Bringing the world together through live experiences . We’re creating the world’s first marketplace for live experiences by developing the technology that lets anyone create, share and find new things to do. For further information please visit:



Select Science is the leading online product and application publication for laboratory scientists featuring the latest news, application articles, videos, product directory and product reviews. Membership is fast, free and provides access to all of the SelectScience services. is a unique video news channel for laboratory application and product information. For further information please visit:

pharmiweb is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email:,


BioProcess International

BioProcess International™ is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.


Global Events List

Global Events List is an online directory of scientific and medical events from around the world, brought to you by Elsevier. Attending these types of events facilitates the proliferation of scientific discoveries and the building of productive relationships. We hope to play our part by providing the most comprehensive, user-friendly, reliable, and high quality listing of events available.


Manufacturing Chemist Pharma

Manufacturing Chemist is among the longest established and most respected information sources in the global pharmaceutical manufacturing industry. Manufacturing Chemist reports on current and future trends in the global marketplace, including the latest developments in drug discovery, biotechnology, drug delivery, ingredients, processing technologies and equipment, packaging, business strategies and regulatory updates. – See more at:



FiercePharma is the pharma industry’s daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products.


Pharma Phorum is the premier digital publication for thought leadership relating to the pharmaceutical industry. The news, opinions and insights published every day help industry executives better understand the broader healthcare landscape within which they operate, including regular contributions from their peers, innovative service providers, physicians, payers / policy makers, patient organisations and patients.


Pharmafile is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, and pharma service company listings. Site content is produced by our editorial team for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches.


My Event Guru

My Event Guru is an interactive portal that allows individuals and businesses to set up, market and promote events, sell tickets and collect RSVP’s, instantly process payments for events online, obtain feedback via sophisticated surveys and generate additional revenue by selling event content.
Our mission is to be your comprehensive local business event resource. We strive to be the one-stop solution for anyone looking to promote their events, take advantage of our event tools, and generate additional revenue from event content. We are committed to helping you make and maintain local connections and relationships that will make a difference your business and your career.



Bio-equip is a professional website which provides the information of equipments, consumables, chemical reagents and experimental animals in life science. Our website which takes full advantage of the most up-to-date computer technologies and networks offers the most all-round and considerate service in the information of biology equipments for not only institutes, universities, labs in hospitals but also scientists in bio-engineering and bio-medicine industries and suppliers of lab equipments who would be exposed to comprehensive and well-timed market information to compare the different products in function and price and promote the development of scientific research and industry.

pharma-tech is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field. Our international scope allows us to examine all pharmaceutical markets closely, from biotechnology to therapeutics, vaccines and more.



Conference Alerts is an online conference calendar for academics and professionals. Organizers post conference information on and subscribers receive alerts about conferences in their areas of interest via email.



Conferize is the world’s biggest social platform for events. You’re invited.We connect the world of events with speakers, people and media from any industry. We help event organizers build communities, websites and mobile experiences to increase the quality and attendance of their events.


Originally, was created solely as a directory of conferences, but due to popular demand we are now offering other services. Currently these include:
• Featured Listings
• Advertising Opportunities
• Online Registration Services
In the future we plan to offer even more services. If you have any requests or suggestions,
we would love to hear from you. Just drop us an email here: